25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Greenwich LifesciencesĀ Inc
Buy, Hold or Sell?

Let's analyze Greenwich LifesciencesĀ Inc together

I guess you are interested in Greenwich LifesciencesĀ Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Greenwich LifesciencesĀ Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Greenwich LifesciencesĀ Inc

I send you an email if I find something interesting about Greenwich LifesciencesĀ Inc.

1. Quick Overview

1.1. Quick analysis of Greenwich LifesciencesĀ Inc (30 sec.)










1.2. What can you expect buying and holding a share of Greenwich LifesciencesĀ Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.38
Expected worth in 1 year
$0.08
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.29
Return On Investment
-2.2%

For what price can you sell your share?

Current Price per Share
$13.48
Expected price per share
$11.38 - $17.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Greenwich LifesciencesĀ Inc (5 min.)




Live pricePrice per Share (EOD)
$13.48
Intrinsic Value Per Share
$-9.87 - $-11.66
Total Value Per Share
$-9.49 - $-11.29

2.2. Growth of Greenwich LifesciencesĀ Inc (5 min.)




Is Greenwich LifesciencesĀ Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$4.9m$11.1m-$5.4m-95.8%

How much money is Greenwich LifesciencesĀ Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.6m-$2.1m-$456.7k-17.4%
Net Profit Margin-11,411.9%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Greenwich LifesciencesĀ Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#693 / 949

Most Revenue
#782 / 949

Most Profit
#336 / 949

Most Efficient
#875 / 949
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Greenwich LifesciencesĀ Inc?

Welcome investor! Greenwich LifesciencesĀ Inc's management wants to use your money to grow the business. In return you get a share of Greenwich LifesciencesĀ Inc.

First you should know what it really means to hold a share of Greenwich LifesciencesĀ Inc. And how you can make/lose money.

Speculation

The Price per Share of Greenwich LifesciencesĀ Inc is $13.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Greenwich LifesciencesĀ Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Greenwich LifesciencesĀ Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.38. Based on the TTM, the Book Value Change Per Share is $-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Greenwich LifesciencesĀ Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.20-1.5%-0.20-1.5%-0.16-1.2%-0.12-0.9%-0.12-0.9%
Usd Book Value Change Per Share-0.07-0.5%-0.07-0.5%-0.12-0.9%0.020.1%0.020.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.07-0.5%-0.07-0.5%-0.12-0.9%0.020.1%0.020.1%
Usd Price Per Share14.37-15.52-11.87-16.51-16.51-
Price to Earnings Ratio-17.69--19.63--18.46--48.28--48.28-
Price-to-Total Gains Ratio-211.58--35.27--99.18--140.76--140.76-
Price to Book Ratio37.91-37.09-13.92-16.36-16.36-
Price-to-Total Gains Ratio-211.58--35.27--99.18--140.76--140.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.48
Number of shares74
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.070.02
Usd Total Gains Per Share-0.070.02
Gains per Quarter (74 shares)-5.451.40
Gains per Year (74 shares)-21.795.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-22-3206-4
20-44-540112
30-65-760178
40-87-9802214
50-109-12002820
60-131-14203426
70-153-16403932
80-174-18604538
90-196-20805044
100-218-23005650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.020.00.00.0%0.020.00.00.0%
Book Value Change Per Share1.03.00.025.0%1.011.00.08.3%4.015.01.020.0%4.015.01.020.0%4.015.01.020.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.020.00.0%0.00.020.00.0%
Total Gains per Share1.03.00.025.0%1.011.00.08.3%4.015.01.020.0%4.015.01.020.0%4.015.01.020.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Greenwich LifesciencesĀ Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.068-0.074+8%-0.125+84%0.019-458%0.019-458%
Book Value Per Share--0.3790.431-12%0.844-55%0.994-62%0.994-62%
Current Ratio--6.91512.532-45%42.210-84%34.900-80%34.900-80%
Debt To Asset Ratio--0.1450.111+30%0.025+483%5.521-97%5.521-97%
Debt To Equity Ratio--0.1690.130+30%0.025+563%0.056+201%0.056+201%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--193869322.000207957052.750-7%167103606.375+16%270551203.971-28%270551203.971-28%
Eps---0.203-0.200-2%-0.162-20%-0.117-42%-0.117-42%
Ev To Ebitda Ratio---17.766infnan%-18.024+1%infnan%infnan%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.197-0.144-27%-0.124-37%-0.104-47%-0.104-47%
Free Cash Flow To Equity Per Share---0.107-0.063-41%-0.267+150%0.038-379%0.038-379%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---11.664--------
Intrinsic Value_10Y_min---9.869--------
Intrinsic Value_1Y_max---0.612--------
Intrinsic Value_1Y_min---0.600--------
Intrinsic Value_3Y_max---2.262--------
Intrinsic Value_3Y_min---2.151--------
Intrinsic Value_5Y_max---4.425--------
Intrinsic Value_5Y_min---4.071--------
Market Cap177190556.000-7%188889339.000204038605.750-7%156011158.125+21%217055144.925-13%217055144.925-13%
Net Profit Margin----114.1190%-0%-22.8240%-22.8240%
Operating Margin----117.0730%-0%-23.4150%-23.4150%
Operating Ratio---117.073-100%-0%23.415-100%23.415-100%
Pb Ratio35.561-7%37.90937.086+2%13.916+172%16.358+132%16.358+132%
Pe Ratio-16.599+6%-17.695-19.634+11%-18.455+4%-48.275+173%-48.275+173%
Price Per Share13.480-7%14.37015.523-7%11.869+21%16.513-13%16.513-13%
Price To Free Cash Flow Ratio-17.144+6%-18.275-31.303+71%-25.259+38%-54.161+196%-54.161+196%
Price To Total Gains Ratio-198.473+6%-211.577-35.274-83%-99.178-53%-140.758-33%-140.758-33%
Quick Ratio--6.9126.596+5%42.210-84%33.704-79%33.704-79%
Return On Assets---0.458-0.415-9%-0.194-58%-1.275+178%-1.275+178%
Return On Equity---0.536-0.468-13%-0.199-63%-0.161-70%-0.161-70%
Total Gains Per Share---0.068-0.074+8%-0.125+84%0.019-458%0.019-458%
Usd Book Value--4982665.0005669839.500-12%11100096.750-55%13065476.800-62%13065476.800-62%
Usd Book Value Change Per Share---0.068-0.074+8%-0.125+84%0.019-458%0.019-458%
Usd Book Value Per Share--0.3790.431-12%0.844-55%0.994-62%0.994-62%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--193869322.000207957052.750-7%167103606.375+16%270551203.971-28%270551203.971-28%
Usd Eps---0.203-0.200-2%-0.162-20%-0.117-42%-0.117-42%
Usd Free Cash Flow---2583932.000-1892133.000-27%-1623617.000-37%-1360526.450-47%-1360526.450-47%
Usd Free Cash Flow Per Share---0.197-0.144-27%-0.124-37%-0.104-47%-0.104-47%
Usd Free Cash Flow To Equity Per Share---0.107-0.063-41%-0.267+150%0.038-379%0.038-379%
Usd Market Cap177190556.000-7%188889339.000204038605.750-7%156011158.125+21%217055144.925-13%217055144.925-13%
Usd Price Per Share13.480-7%14.37015.523-7%11.869+21%16.513-13%16.513-13%
Usd Profit---2668713.000-2623832.250-2%-2167104.000-19%-1542884.900-42%-1542884.900-42%
Usd Revenue---1354.500-100%-0%270.900-100%270.900-100%
Usd Total Gains Per Share---0.068-0.074+8%-0.125+84%0.019-458%0.019-458%
 EOD+3 -5MRQTTM+7 -27YOY+12 -205Y+4 -3010Y+4 -30

3.3 Fundamental Score

Let's check the fundamental score of Greenwich LifesciencesĀ Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-16.599
Price to Book Ratio (EOD)Between0-135.561
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than16.912
Current Ratio (MRQ)Greater than16.915
Debt to Asset Ratio (MRQ)Less than10.145
Debt to Equity Ratio (MRQ)Less than10.169
Return on Equity (MRQ)Greater than0.15-0.536
Return on Assets (MRQ)Greater than0.05-0.458
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Greenwich LifesciencesĀ Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.262
Ma 20Greater thanMa 5013.672
Ma 50Greater thanMa 10013.727
Ma 100Greater thanMa 20014.135
OpenGreater thanClose13.700
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Greenwich LifesciencesĀ Inc

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Fundamental data was last updated by Penke on 2024-12-05 21:02:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitĀ Greenwich LifesciencesĀ Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Ā means thatĀ $0.00 for each $1Ā in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-11,411.9%+11,411.9%
TTM-11,411.9%YOY--11,411.9%
TTM-11,411.9%5Y-2,282.4%-9,129.5%
5Y-2,282.4%10Y-2,282.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--108.0%+108.0%
TTM-11,411.9%-218.6%-11,193.3%
YOY--210.1%+210.1%
5Y-2,282.4%-339.1%-1,943.3%
10Y-2,282.4%-464.5%-1,817.9%
4.3.1.2. Return on Assets

Shows howĀ efficientĀ Greenwich LifesciencesĀ Inc is using its assets to generate profit.

  • Above 5% is considered healthyĀ but always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • -45.8% Return on Assets means thatĀ Greenwich LifesciencesĀ Inc generatedĀ $-0.46 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is -45.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -41.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.8%TTM-41.5%-4.3%
TTM-41.5%YOY-19.4%-22.1%
TTM-41.5%5Y-127.5%+86.0%
5Y-127.5%10Y-127.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.8%-11.3%-34.5%
TTM-41.5%-11.8%-29.7%
YOY-19.4%-11.3%-8.1%
5Y-127.5%-12.6%-114.9%
10Y-127.5%-14.2%-113.3%
4.3.1.3. Return on Equity

Shows how efficient Greenwich LifesciencesĀ Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • -53.6% Return on Equity means Greenwich LifesciencesĀ Inc generated $-0.54Ā for eachĀ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is -53.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -46.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-53.6%TTM-46.8%-6.8%
TTM-46.8%YOY-19.9%-26.9%
TTM-46.8%5Y-16.1%-30.7%
5Y-16.1%10Y-16.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-53.6%-14.2%-39.4%
TTM-46.8%-15.9%-30.9%
YOY-19.9%-14.4%-5.5%
5Y-16.1%-18.5%+2.4%
10Y-16.1%-19.5%+3.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Greenwich LifesciencesĀ Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresĀ how efficient Greenwich LifesciencesĀ Inc is operatingĀ .

  • Measures how much profit Greenwich LifesciencesĀ Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • An Operating Margin of 0.0%Ā means the company generated $0.00 Ā for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-11,707.3%+11,707.3%
TTM-11,707.3%YOY--11,707.3%
TTM-11,707.3%5Y-2,341.5%-9,365.8%
5Y-2,341.5%10Y-2,341.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.6%+204.6%
TTM-11,707.3%-313.2%-11,394.1%
YOY--219.0%+219.0%
5Y-2,341.5%-388.9%-1,952.6%
10Y-2,341.5%-495.6%-1,845.9%
4.3.2.2. Operating Ratio

Measures how efficient Greenwich LifesciencesĀ Inc is keepingĀ operating costsĀ low.

  • Below 1 is considered healthy (always compare toĀ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM117.073-117.073
TTM117.073YOY-+117.073
TTM117.0735Y23.415+93.658
5Y23.41510Y23.4150.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.340-2.340
TTM117.0733.187+113.886
YOY-3.282-3.282
5Y23.4154.814+18.601
10Y23.4156.494+16.921
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Greenwich LifesciencesĀ Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Greenwich LifesciencesĀ Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toĀ Biotechnology industry mean).
  • A Current Ratio of 6.91Ā means the company has $6.91 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 6.915. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.532. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.915TTM12.532-5.617
TTM12.532YOY42.210-29.678
TTM12.5325Y34.900-22.369
5Y34.90010Y34.9000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9153.645+3.270
TTM12.5323.883+8.649
YOY42.2104.666+37.544
5Y34.9005.964+28.936
10Y34.9006.265+28.635
4.4.3.2. Quick Ratio

Measures if Greenwich LifesciencesĀ Inc is able to pay off Short-term Debt but only usingĀ theĀ most liquid assets.

  • Above 1 is considered healthy butĀ always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • A Quick Ratio of 6.91Ā means the company can pay off $6.91 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 6.912. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.596. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.912TTM6.596+0.316
TTM6.596YOY42.210-35.614
TTM6.5965Y33.704-27.108
5Y33.70410Y33.7040.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.9123.014+3.898
TTM6.5963.418+3.178
YOY42.2104.456+37.754
5Y33.7045.970+27.734
10Y33.7046.424+27.280
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Greenwich LifesciencesĀ Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Ā of Greenwich LifesciencesĀ IncĀ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareĀ Greenwich LifesciencesĀ Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.14Ā means that Greenwich LifesciencesĀ Inc assets areĀ financed with 14.5% credit (debt) and the remaining percentage (100% - 14.5%)Ā is financed by its owners/shareholders.Ā 

Let's take a look of the Debt to Asset Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.145. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.111. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.111+0.033
TTM0.111YOY0.025+0.086
TTM0.1115Y5.521-5.409
5Y5.52110Y5.5210.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1450.350-0.205
TTM0.1110.341-0.230
YOY0.0250.310-0.285
5Y5.5210.365+5.156
10Y5.5210.382+5.139
4.5.4.2. Debt to Equity Ratio

Measures ifĀ Greenwich LifesciencesĀ Inc is able toĀ pay off its debts by usingĀ shareholders equity.

  • Below 2 is considered healthy butĀ always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • A Debt to Equity ratio of 16.9% means that company has $0.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Greenwich LifesciencesĀ Inc:

  • The MRQ is 0.169. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.130. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.169TTM0.130+0.039
TTM0.130YOY0.025+0.104
TTM0.1305Y0.056+0.074
5Y0.05610Y0.0560.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1690.394-0.225
TTM0.1300.432-0.302
YOY0.0250.380-0.355
5Y0.0560.451-0.395
10Y0.0560.490-0.434
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresĀ how much money you payĀ for each share forĀ every $1 in earnings Greenwich LifesciencesĀ Inc generates.

  • Above 15 is considered overpriced butĀ always compareĀ Greenwich LifesciencesĀ Inc to theĀ Biotechnology industry mean.
  • A PE ratio of -17.69 means the investor is paying $-17.69Ā for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Greenwich LifesciencesĀ Inc:

  • The EOD is -16.599. Based on the earnings, the company is expensive. -2
  • The MRQ is -17.695. Based on the earnings, the company is expensive. -2
  • The TTM is -19.634. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.599MRQ-17.695+1.096
MRQ-17.695TTM-19.634+1.939
TTM-19.634YOY-18.455-1.179
TTM-19.6345Y-48.275+28.641
5Y-48.27510Y-48.2750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.599-2.315-14.284
MRQ-17.695-2.491-15.204
TTM-19.634-3.156-16.478
YOY-18.455-3.274-15.181
5Y-48.275-6.037-42.238
10Y-48.275-6.785-41.490
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Greenwich LifesciencesĀ Inc:

  • The EOD is -17.144. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.275. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -31.303. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.144MRQ-18.275+1.132
MRQ-18.275TTM-31.303+13.028
TTM-31.303YOY-25.259-6.044
TTM-31.3035Y-54.161+22.858
5Y-54.16110Y-54.1610.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-17.144-2.985-14.159
MRQ-18.275-3.361-14.914
TTM-31.303-3.734-27.569
YOY-25.259-4.557-20.702
5Y-54.161-8.327-45.834
10Y-54.161-9.311-44.850
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofĀ Greenwich LifesciencesĀ Inc is to cheap or to expensiveĀ compared to its book value.

  • At or below 1 is considered healthyĀ (always compare to Biotechnology industry mean).
  • A PB ratio of 37.91 means the investor is paying $37.91Ā for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Greenwich LifesciencesĀ Inc:

  • The EOD is 35.561. Based on the equity, the company is expensive. -2
  • The MRQ is 37.909. Based on the equity, the company is expensive. -2
  • The TTM is 37.086. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD35.561MRQ37.909-2.348
MRQ37.909TTM37.086+0.823
TTM37.086YOY13.916+23.170
TTM37.0865Y16.358+20.728
5Y16.35810Y16.3580.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD35.5611.919+33.642
MRQ37.9092.051+35.858
TTM37.0862.374+34.712
YOY13.9162.454+11.462
5Y16.3583.737+12.621
10Y16.3584.378+11.980
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Greenwich LifesciencesĀ Inc.

4.8.1. Institutions holding Greenwich LifesciencesĀ Inc

Institutions are holding 8.696% of the shares of Greenwich LifesciencesĀ Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30BlackRock Inc2.35010.0001308909252450447.1386
2024-09-30Vanguard Group Inc2.08090.000127352553571.9976
2024-09-30Geode Capital Management, LLC1.0160.000213355058614.5901
2024-09-30CrƩdit Agricole S.A.0.66190.00548700000
2024-09-30Northern Trust Corp0.56680.00027450050180206.3322
2024-09-30State Street Corp0.543207140830054.3931
2024-09-30Renaissance Technologies Corp0.24720.000732500-4400-11.9241
2024-09-30Garden State Investment Advisory Services LLC0.13390.069717600176000
2024-09-30Morgan Stanley - Brokerage Accounts0.1296017031292520.7359
2024-09-30Charles Schwab Investment Management Inc0.12520.000116455-1999-10.8323
2024-09-30STRS OHIO0.09740.0007128008000166.6667
2024-09-30Bank of New York Mellon Corp0.0852011203-4092-26.7538
2024-09-30Millennium Management LLC0.08090.000110638106380
2024-09-30Barclays PLC0.0651085606538323.3432
2024-06-30Bank of America Corp0.04810632869312.2981
2024-09-30Rhumbline Advisers0.04790.00016302-497-7.3099
2024-09-30New York State Common Retirement Fund0.04560.0001600000
2024-09-30Citigroup Inc0.0328043083009231.6397
2024-09-30MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.0.02530.0001333033300
2024-09-30Corebridge Financial Inc0.02430.00023191-21-0.6538
Total 8.40740.07781105138+358577+32.4%

4.9.2. Funds holding Greenwich LifesciencesĀ Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv1.16750.000115345900
2024-11-27iShares Russell 2000 ETF1.16090.0028152598-322-0.2106
2024-06-30PV BUYBACK USA Classe B USD0.66191.99988700000
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr0.54250.00097131100
2024-08-31Fidelity Small Cap Index0.46940.003261696-1121-1.7845
2024-11-27iShares Russell 2000 Growth ETF0.38910.00565114100
2024-09-30Fidelity Extended Market Index0.25250.00113319319366.1938
2024-10-31State St Russell Sm CapĀ® Indx SL Cl I0.21680.0042850000
2024-10-31Vanguard Russell 2000 ETF0.2070.00327208-170-0.6209
2024-09-30NT R2000 Index Fund - NL0.11110.003214610146100
2024-11-27iShares Micro-Cap ETF0.10750.02071412900
2024-10-31Schwab Small Cap Index0.10490.00291378400
2024-09-30NT R2000 Growth Index Fund - L0.10290.006713525135250
2024-09-30Northern Trust Russell 2000 Growth Index0.10290.006713525135250
2024-10-31iShares Russell 2000 Small-Cap Idx Instl0.09050.00331190200
2024-09-30NT R2000 Index Fund - DC - NL - 20.0890.003211699116990
2024-09-30Fidelity Total Market Index0.08140.000210697268633.5289
2024-09-30BlackRock Extended Equity Market K0.08110.00110655-5-0.0469
2024-10-31The Vanguard Russell 2000 Growth Index0.07740.006101705205.3886
2024-09-30Russell 2000 Index Non-Lendable Fund E0.07670.003310086-1560-13.3952
Total 6.0932.0777800888+55323+6.9%

5.3. Insider Transactions

Insiders are holding 52.928% of the shares of Greenwich LifesciencesĀ Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-11-21Jaye ThompsonBUY100012.91
2024-09-26Snehal PatelBUY150014.63
2024-08-12Jaye ThompsonBUY80013.85
2024-08-05Snehal PatelBUY550013.18
2024-08-02Jaye ThompsonBUY100015.15
2024-07-23Snehal PatelBUY150015.89
2024-07-18Jaye ThompsonBUY100016
2024-06-13Snehal PatelBUY17482514.3
2024-04-01Snehal PatelBUY300019.08
2024-03-22Snehal PatelBUY250019.98
2024-03-20Snehal PatelBUY150017.68
2024-03-04Snehal PatelBUY410013.03
2024-02-15Snehal PatelBUY1270011.07
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets5,825
Total Liabilities842
Total Stockholder Equity4,983
 As reported
Total Liabilities 842
Total Stockholder Equity+ 4,983
Total Assets = 5,825

Assets

Total Assets5,825
Total Current Assets5,825
Long-term Assets3
Total Current Assets
Cash And Cash Equivalents 5,822
Other Current Assets 3
Total Current Assets  (as reported)5,825
Total Current Assets  (calculated)5,825
+/-0
Long-term Assets
Other Assets 3
Long-term Assets  (as reported)3
Long-term Assets  (calculated)3
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities842
Long-term Liabilities0
Total Stockholder Equity4,983
Total Current Liabilities
Accounts payable 775
Other Current Liabilities 68
Total Current Liabilities  (as reported)842
Total Current Liabilities  (calculated)842
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock13
Retained Earnings -58,113
Other Stockholders Equity 63,083
Total Stockholder Equity (as reported)4,983
Total Stockholder Equity (calculated)4,983
+/-0
Other
Cash and Short Term Investments 5,822
Common Stock Shares Outstanding 13,142
Liabilities and Stockholders Equity 5,825
Net Debt -5,822
Net Working Capital 4,983



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
27
0
281
6,274
28,677
30,420
29,815
28,920
27,217
19,755
17,199
15,648
13,477
11,919
10,951
9,150
6,995
5,510
7,228
5,825
5,8257,2285,5106,9959,15010,95111,91913,47715,64817,19919,75527,21728,92029,81530,42028,6776,274281027000
   > Total Current Assets 
0
0
0
7
7
263
6,257
28,660
30,405
29,801
28,906
27,204
19,743
17,188
15,638
13,468
11,911
10,944
9,144
6,989
5,506
7,225
5,825
5,8257,2255,5066,9899,14410,94411,91113,46815,63817,18819,74327,20428,90629,80130,40528,6606,25726377000
       Cash And Cash Equivalents 
0
0
0
7
0
7
6,214
28,660
30,405
29,801
28,906
27,204
19,743
17,188
15,638
13,468
11,911
10,944
9,144
6,989
5,506
7,225
5,822
5,8227,2255,5066,9899,14410,94411,91113,46815,63817,18819,74327,20428,90629,80130,40528,6606,214707000
       Other Current Assets 
0
0
0
0
0
256
43
0
0
0
28,906
0
0
0
0
0
0
0
0
0
0
0
3
30000000000028,9060004325600000
   > Long-term Assets 
0
0
0
20
0
18
17
16
15
14
14
13
12
11
10
9
8
7
6
5
4
4
3
3445678910111213141415161718020000
       Intangible Assets 
0
0
0
20
0
18
17
16
15
14
14
13
12
11
10
9
8
7
6
5
4
4
0
0445678910111213141415161718020000
       Other Assets 
0
0
0
0
0
0
17
16
0
0
0
13
12
11
10
9
8
7
0
0
0
0
3
30000789101112130001617000000
> Total Liabilities 
0
0
0
1,377
0
1,738
1,616
1,045
673
653
455
385
241
229
238
263
236
302
297
294
390
1,353
842
8421,3533902942973022362632382292413854556536731,0451,6161,73801,377000
   > Total Current Liabilities 
0
0
0
1,377
1,447
1,738
1,616
1,045
673
653
455
385
241
229
238
263
236
302
297
294
390
1,353
842
8421,3533902942973022362632382292413854556536731,0451,6161,7381,4471,377000
       Accounts payable 
0
0
0
730
749
767
800
711
609
628
296
221
221
221
221
221
221
80
231
256
126
1,114
775
7751,11412625623180221221221221221221296628609711800767749730000
       Other Current Liabilities 
0
0
0
647
0
971
816
335
64
25
159
164
20
8
17
42
15
222
66
0
264
239
68
6823926406622215421782016415925643358169710647000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
221
221
221
221
221
221
0
0
0
0
0
0
00000022122122122122122100000000000
> Total Stockholder Equity
0
0
0
-1,350
0
-1,458
4,658
27,631
29,747
29,162
28,464
26,832
19,514
16,970
15,410
13,214
11,684
10,650
8,853
6,700
5,121
5,875
4,983
4,9835,8755,1216,7008,85310,65011,68413,21415,41016,97019,51426,83228,46429,16229,74727,6314,658-1,4580-1,350000
   Common Stock
0
0
0
8
23
9
12
13
13
13
13
13
13
13
13
13
13
13
13
0
13
13
13
1313130131313131313131313131313129238000
   Retained Earnings Total Equity00000-45,226-43,5980-38,682-36,363-35,617-33,648-31,287-30,424-29,674-29,0770000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
56,695
59,408
59,573
59,738
60,466
55,118
53,320
54,080
0
55,269
55,863
0
0
0
0
0
0000055,86355,269054,08053,32055,11860,46659,73859,57359,40856,6950000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
25,853
0
26,201
32,572
56,695
59,408
59,573
59,738
60,466
55,118
53,320
54,080
54,674
55,269
55,863
56,458
0
57,946
61,307
63,083
63,08361,30757,946056,45855,86355,26954,67454,08053,32055,11860,46659,73859,57359,40856,69532,57226,201025,853000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-4
Gross Profit-4-4
 
Operating Income (+$)
Gross Profit-4
Operating Expense-9,328
Operating Income-9,328-9,331
 
Operating Expense (+$)
Research Development7,699
Selling General Administrative1,629
Selling And Marketing Expenses4
Operating Expense9,3289,331
 
Net Interest Income (+$)
Interest Income451
Interest Expense-0
Other Finance Cost-0
Net Interest Income451
 
Pretax Income (+$)
Operating Income-9,328
Net Interest Income451
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,892-9,764
EBIT - interestExpense = -9,328
-8,892
-8,892
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-9,328-8,892
Earnings Before Interest and Taxes (EBITDA)-9,324
 
After tax Income (+$)
Income Before Tax-8,892
Tax Provision-0
Net Income From Continuing Ops-8,936-8,892
Net Income-8,892
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses9,328
Total Other Income/Expenses Net436-451
 

Technical Analysis of Greenwich LifesciencesĀ Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Greenwich LifesciencesĀ Inc. The general trend of Greenwich LifesciencesĀ Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Greenwich LifesciencesĀ Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportĀ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceĀ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Greenwich LifesciencesĀ Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 15.50 < 16.50 < 17.00.

The bearish price targets are: 12.20 > 11.89 > 11.38.

Tweet this
Greenwich LifesciencesĀ Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows theĀ moving averageĀ of the selected period.

  • Moving averages are laggingĀ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Greenwich LifesciencesĀ Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Greenwich LifesciencesĀ Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theĀ momentumĀ of theĀ selected period based on two moving averages.

  • MACD is aĀ lagging momentumĀ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Greenwich LifesciencesĀ Inc. The current macd is 0.10336246.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Greenwich LifesciencesĀ Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Greenwich LifesciencesĀ Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Greenwich LifesciencesĀ Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Greenwich LifesciencesĀ Inc Daily Moving Average Convergence/Divergence (MACD) ChartGreenwich LifesciencesĀ Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Greenwich LifesciencesĀ Inc. The current adx is 15.31.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Greenwich LifesciencesĀ Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Greenwich LifesciencesĀ Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsĀ the current trend.
  • ShowsĀ potential entry signals.
  • ShowsĀ Ā potential exit signals.
  • Can be used to placeĀ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Greenwich LifesciencesĀ Inc. The current sar is 12.92.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Greenwich LifesciencesĀ Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumĀ indicator, meaning the signals are instant.
  • RangesĀ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Greenwich LifesciencesĀ Inc. The current rsi is 48.26. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Greenwich LifesciencesĀ Inc Daily Relative Strength Index (RSI) ChartGreenwich LifesciencesĀ Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesĀ a certain price to multiple prices ranging over time.

  • LeadingĀ momentumĀ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesĀ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Greenwich LifesciencesĀ Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Greenwich LifesciencesĀ Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Greenwich LifesciencesĀ Inc Daily Stochastic Oscillator ChartGreenwich LifesciencesĀ Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Ā the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Greenwich LifesciencesĀ Inc. The current cci is -9.20937452.

Greenwich LifesciencesĀ Inc Daily Commodity Channel Index (CCI) ChartGreenwich LifesciencesĀ Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Greenwich LifesciencesĀ Inc. The current cmo is -6.89674687.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Greenwich LifesciencesĀ Inc Daily Chande Momentum Oscillator (CMO) ChartGreenwich LifesciencesĀ Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Ā Shows the current price relative to the highest high over the last 14 days.
Ā 

  • Lagging momentum indicator
  • Ranging between 0 andĀ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Greenwich LifesciencesĀ Inc. The current willr is -56.93883792.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Greenwich LifesciencesĀ Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Greenwich LifesciencesĀ Inc Daily Williams %R ChartGreenwich LifesciencesĀ Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldĀ 

Score

Let's take a look at the Bollinger Bands of Greenwich LifesciencesĀ Inc.

Greenwich LifesciencesĀ Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Greenwich LifesciencesĀ Inc. The current atr is 0.86950192.

Greenwich LifesciencesĀ Inc Daily Average True Range (ATR) ChartGreenwich LifesciencesĀ Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Ā Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Greenwich LifesciencesĀ Inc. The current obv is 861,328.

Greenwich LifesciencesĀ Inc Daily On-Balance Volume (OBV) ChartGreenwich LifesciencesĀ Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Greenwich LifesciencesĀ Inc. The current mfi is 64.53.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Greenwich LifesciencesĀ Inc Daily Money Flow Index (MFI) ChartGreenwich LifesciencesĀ Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Greenwich LifesciencesĀ Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Greenwich LifesciencesĀ Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Greenwich LifesciencesĀ Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.262
Ma 20Greater thanMa 5013.672
Ma 50Greater thanMa 10013.727
Ma 100Greater thanMa 20014.135
OpenGreater thanClose13.700
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Greenwich LifesciencesĀ Inc with someone you think should read this too:
  • Are you bullish or bearish on Greenwich LifesciencesĀ Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Greenwich LifesciencesĀ Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Greenwich LifesciencesĀ Inc

I send you an email if I find something interesting about Greenwich LifesciencesĀ Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Greenwich LifesciencesĀ Inc.

Receive notifications about Greenwich LifesciencesĀ Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.